Vatnak Vat-Ho

Vatnak Vat-Ho

Corporate Officer/Principal en RYVU THERAPEUTICS S.A. .

Fortuna: 224 443 $ al 31/07/2026

Health Technology
Consumer Services
Finance

Perfil

Vatnak Vat-Ho is currently the Chief Business Officer at Ryvu Therapeutics SA. Previously, he worked as an Associate Analyst at Harris Nesbitt Gerard from 2004 to 2006 and as the Head of Business Development & Alliances at Pfizer Inc. from 2014 to 2018.
He also held positions as an Associate Analyst at BMO Capital Markets Corp.
and as the Vice President of Business Development at Affimed, Inc. Mr. Vat-Ho holds an MBA from The Leonard N Stern School of Business and an undergraduate degree from Harvard University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
30/09/2025 57.000 ( 0,25 % ) 224 443 $ 31/07/2026

Cargos activos de Vatnak Vat-Ho

EmpresasCargoInicio
RYVU THERAPEUTICS S.A. Corporate Officer/Principal 26/04/2021

Antiguos cargos conocidos de Vatnak Vat-Ho.

EmpresasCargoFin
PFIZER INC. Corporate Officer/Principal 01/06/2018
Analyst-Equity 14/06/2006
Affimed, Inc.
Corporate Officer/Principal -
Analyst-Equity -
Ver el detalle de la experiencia de Vatnak Vat-Ho.

Formación de Vatnak Vat-Ho.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

95

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Consumer Services

Finance

Finance

Health Technology

Consumer Services

Affimed, Inc.